Go Pro
OTCMKTS:SSMXY

Sysmex Q3 2026 Earnings Report

Sysmex logo
$12.13 0.00 (0.00%)
As of 09/25/2026 03:58 PM Eastern

Sysmex EPS Results

Actual EPS
$0.15
Consensus EPS
$0.14
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Sysmex Revenue Results

Actual Revenue
$837.32 million
Expected Revenue
$819.99 million
Beat/Miss
Beat by +$17.33 million
YoY Revenue Growth
N/A

Sysmex Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Sysmex's next earnings date is estimated for Wednesday, November 4, 2026, based on past reporting schedules.

Conference Call Resources

Sysmex Earnings Headlines

Sysmex Corp (SSMXY)
First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel
Sysmex Corp (SSMXY) Ratios
See More Sysmex Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sysmex? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sysmex and other key companies, straight to your email.

About Sysmex

Sysmex (OTCMKTS:SSMXY) Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic instruments, reagents and related information systems. Its products are primarily used in clinical laboratories, hospitals and other healthcare settings to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology testing systems, including automated analyzers used to assess blood cell counts and related parameters. Its portfolio also includes products for hemostasis and coagulation testing, urinalysis, clinical chemistry, immunochemistry and flow cytometry, as well as laboratory information systems, maintenance and other support services.

Sysmex was established in 1968 and is headquartered in Kobe, Japan. The company serves healthcare institutions and laboratory customers internationally through operations, subsidiaries and distribution networks spanning Japan and other markets in Asia, the Americas, Europe and additional regions. Its business combines recurring demand for diagnostic reagents and services with the sale and support of laboratory equipment.

View Sysmex Profile